Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Molecular Cancer|March 10, 2012
IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumorsIvonne Regel, Melanie Eichenmüller, Saskia Joppien, et al.
European Journal of Medicinal Chemistry|February 25, 2016
Three stories on Eph kinase inhibitors: From in silico discovery to in vivo validationAndrea Unzue, Karine Lafleur, Hongtao Zhao, et al.
Oncotarget|October 27, 2015
Anti-leukemic effects of the V-ATPase inhibitor Archazolid ASiwei Zhang, Lina S Schneider, Binje Vick, et al.
Plos One|January 22, 2013
Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitorsSabine B Weitensteiner, Johanna Liebl, Vladimir Krystof, et al.
Cardiovascular Research|September 21, 2014
In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitorMagdalena H Menhofer, Dominik Bartel, Johanna Liebl, et al.
Cancer Research|May 29, 2015
Vacuolar-ATPase Inhibition Blocks Iron Metabolism to Mediate Therapeutic Effects in Breast CancerLina S Schneider, Karin von Schwarzenberg, Thorsten Lehr, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 9, 2018
The novel brassinosteroid analog BR4848 inhibits angiogenesis in human endothelial cells and induces apoptosis in human cancer cells in vitroLucie Rárová, David Sedlák, Jana Oklestkova, et al.
Oncotarget|March 31, 2016
Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinomaJulia Herzog, Sandra M Ehrlich, Lisa Pfitzer, et al.
Angiogenesis|April 14, 2011
Anti-angiogenic effects of purine inhibitors of cyclin dependent kinasesJohanna Liebl, Vladimir Krystof, György Vereb, et al.
Oncotarget|January 13, 2016
Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesisHenriette Merk, Siwei Zhang, Thorsten Lehr, et al.
Pageof 3